The capsule shells have the following inactive ingredients: gelatin, FD C Blue #1, FD C Red #40, D C Red #28, titanium dioxide, shellac, ethyl alcohol, isopropyl alcohol, n-butyl alcohol, propylene glycol, sodium hydroxide, polyvinyl pyrrolidone, and D C Yellow #10.
Looking for online definition of domperidone in the Medical Dictionary? domperidone explanation free. What is domperidone? Meaning of domperidone medical term.Domperidone. Definition from Wiktionary, the free dictionary. Jump to: navigation, search. English. Wikipedia has an article on: domperidone.
Although not all of these side effects may occur, if they do occur they may need medical attention. Symptoms of overdose Get emergency help immediately if any of the following symptoms of overdose occur: Difficulty in speaking disorientation dizziness fainting irregular heartbeat light-headedness loss of.These.
Visit the. FDA MedWatch website or call 1-800-FDA-1088. Need help identifying pills and medications? Use the pill identifier tool on RxList. Back to Medications Index.USES : This medication increases movement through the digestive system. It is used to treat symptoms of stomach disorders. It may.
A single 4 mg intravenous dose of domperidone produced peak TSH levels of 1.9-fold above baseline and peak. domperidone 1 mg/ml, 30 ml suspension. India.
What form(s) does this medication come in? Each white, round, biconvex, film-coated tablet, engraved APO on one side and 10 on the other, contains domperidone maleate equivalent to domperidone 10 mg. Nonmedicinal ingredients: colloidal silicon dioxide, croscarmellose sodium, fumaric acid, hydroxypropyl methylcellulose, magnesium stearate, microcrystalline cellulose.Seniors.
Concomitant use of the following substances is not recommended. Moderate CYP3A4 inhibitors i.e. diltiazem, verapamil and some macrolides. (see section 4.3) Concomitant use of the following substances requires caution in use. 4.5 Interaction with other medicinal products and other forms of interaction. The main metabolic pathway of domperidone is through CYP3A4. In vitro data suggest that the concomitant use of drugs that significantly inhibit this enzyme may result in increased plasma levels of creased risk of.
Renal Impairment. The elimination half-life of domperidone is prolonged in severe renal impairment. For repeated administration, the dosing frequency of domperidone should be reduced to once or twice daily depending on the severity of the impairment.
4.4 Special warnings and precautions for use. Precautions for use Domperidone tablets contain lactose and may be unsuitable for patients with lactose intolerance, galactosaemia or glucose/galactose malabsorption. Use in infants Neurological side effects are rare (see "Undesirable effects" section).
Since metabolic functions and the blood-brain barrier are not fully developed in the first months of life the risk of neurological side effects is higher in young children. Overdosing may cause extrapyramidal symptoms in children, but other causes should be taken into consideration.
If taken after meals, absorption of the drug is somewhat tients should try to take each dose at scheduled time. If a scheduled dose is missed, the missed dose should be omitted and the usual dosing schedule resumed.
Co-administration with potent CY3A4 inhibitors (regardless of their QT prolonging effects) (see section 4.5) Known hypersensitivity to domperidone or any of the excipients. Prolactin-releasing pituitary tumour (prolactinoma.) Renal impairmentDomperidone should not be used when stimulation of gastric motility could be harmful: gastro-intestinal haemorrhage, mechanical obstruction.
The dose should not be doubled to make up for a missed ually, the maximum treatment duration should not exceed one week. Adults and adolescents (12 years of age and older and weighing 35 kg or more) One 10mg tablet up to three times per.
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.
Domperidone is contraindicated in patients with known existing prolongation of cardiac conduction intervals, particularly QTc, in patients with significant electrolyte disturbances (hypokalaemia, hyperkalaemia, hypomagnesaemia or bradycardia, or in patient with underlying cardiac diseases such as congestive heart failure due to increased risk of ventricular arrhythmia.